C
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13D/A74.5 KBCHINOOK THERAPEUTICS, INC.Nov 22, 4:15 PM ET·0001104659-23-120754
- SC 13D1.1 MBCHINOOK THERAPEUTICS, INC.Aug 11, 5:17 PM ET·0000908834-23-000097
- 8-K245.2 KBCHINOOK THERAPEUTICS, INC.Aug 11, 4:31 PM ET·0001193125-23-210803
- 10-Q13.3 MBCHINOOK THERAPEUTICS, INC.Aug 7, 4:05 PM ET·0000950170-23-039041
- 8-K149.3 KBCHINOOK THERAPEUTICS, INC.Aug 3, 4:06 PM ET·0001193125-23-202849
- SC 13G/A10.9 KBCHINOOK THERAPEUTICS, INC.Aug 1, 8:56 AM ET·0001088875-23-000101
- 8-K191.2 KBCHINOOK THERAPEUTICS, INC.Jul 28, 8:15 AM ET·0001193125-23-196908
- 8-K213.3 KBCHINOOK THERAPEUTICS, INC.Jun 20, 9:00 AM ET·0001193125-23-169726
- 8-K163.3 KBCHINOOK THERAPEUTICS, INC.Jun 15, 4:17 PM ET·0001193125-23-167916
- 8-K489.4 KBCHINOOK THERAPEUTICS, INC.Jun 12, 4:28 PM ET·0001193125-23-165337
Insiders
10- AKKARAJU SRINIVASDirector
- Azelby RobertDirector
- BJERKHOLT ERICChief Financial Officer
- Brockstedt Dirk G.EVP of Research and Dev.
- Chan GeraldDirector
- DOBMEIER ERICDirector, President, CEO
- Dubensky Thomas W.Chief Scientific Officer
- Ferber CelesteSVP, GC and Secretary
- Frohlich TomChief Operating Officer
- Glicklich AlanChief Medical Officer
Tickers
No tickers on record
Addresses
business
400 FAIRVIEW AVENUE NORTH, SUITE 900
SEATTLE, WA, 98109
mailing
400 FAIRVIEW AVENUE NORTH, SUITE 900
SEATTLE, WA, 98109
Former Names
- ADURO BIOTECH, INC.2020-10-15
- ADURO BIOTECH2011-04-22